Document:

Amended and Restated Employment Agreement

 Exhibit 10.5 
 AMENDED AND RESTATED 
 EMPLOYMENT AGREEMENT 
 This Amended and Restated Employment Agreement (the “Agreement”) between PAUL A. ROSENBAUM (“Rosenbaum”) and RENTRAK
CORPORATION, an Oregon corporation (the “Corporation”), initially entered into as of October 1, 2001, is being amended and restated as set forth herein effective June 15, 2009. 
 1. SERVICES 
 1.1 Employment Position.
Corporation agrees to employ Rosenbaum as Chairman of the Board of Corporation, and Rosenbaum accepts such employment, under the terms and conditions of this Agreement. Rosenbaum also agrees to serve, if elected, without separate compensation, as a
director of Corporation and an officer and/or director of any subsidiary or affiliate of Corporation. 
 1.2 Term. The term of this
Agreement (the “Term”) will commence on June 16, 2009 and expire on September 30, 2011. 
 1.3 Duties. Beginning
June 16, 2009, Rosenbaum will cease serving as Chief Executive Officer and will serve in a non-executive capacity as the Chairman of the Board of Corporation. Rosenbaum, in his capacity as Chairman of the Board, will remain an employee of
Corporation and will perform such duties and exercise such powers commonly incident to such office, including such duties and powers as may be assigned to or vested in Rosenbaum by the Corporation’s Board of Directors (the “Board”).
Rosenbaum’s change in status under this Section 1.3 shall not give rise to a termination for “Good Reason” under Section 5.4. Rosenbaum will do such traveling as may be required in the performance of his duties under this
Agreement. 
 1.4 Outside Activities. During his service as Chairman of the Board, Rosenbaum will devote a minimum of 50 percent of
his business time and attention to the business and affairs of Corporation. At all times, Rosenbaum will perform his services faithfully, competently, and to the best of his abilities. 
 1.5 Application of Corporate Policies. Rosenbaum will, except as otherwise provided in this Agreement, be subject to Corporation’s rules,
practices, and policies applicable generally to Corporation’s directors and employees, as such rules, practices, and policies may be revised from time to time by the Board. 
 2. COMPENSATION AND EXPENSES 
 2.1 Base Salary. As compensation for services under this
Agreement, Corporation will pay to Rosenbaum a base salary of $489,000 per year through September 30, 2010, and $325,000 per year from October 1, 2010, through the end of the Term, each payable in a manner consistent with
Corporation’s payroll practices for management employees, as such practices may be revised from time to time. 
 2.2 Additional
Employee Benefits. 
 2.2.1 During Term. At all times during the Term, Rosenbaum will be entitled to all employee
benefits approved by the Board, or available to officers and other management employees generally, including any life and medical insurance plans, 401(k) and other similar plans, and health and welfare plans, each whether now existing or
hereafter approved by the Board (“Benefit Plans”). The foregoing will not be construed to require Corporation to establish any such plans or to prevent Corporation from modifying or terminating any such Benefit Plans. Through
December 31, 2009, Corporation will also lease an automobile (in an amount up to $900 per month) at its expense for Rosenbaum’s use in the performance of his duties and will pay such expenses in connection with the automobile as are
customarily paid for senior management of corporations substantially similar to Corporation; provided, however, any portion of the automobile related expenses and lease payments made by Corporation attributable to Rosenbaum’s 

  

					
	EMPLOYMENT AGREEMENT	  	-1-	  	

 
personal use of the automobile will be reflected in Rosenbaum’s reported compensation for income tax purposes in accordance with Corporation’s
regular payroll practices. 
 2.2.2 Upon Expiration of Term. Corporation will continue to provide Rosenbaum with all
medical, dental, group life, long-term care and long-term disability insurance benefits to which Rosenbaum was entitled prior to the expiration of the Term until September 30, 2013; provided that such continued participation is possible
under the general terms and provisions of such benefit plans or insurance policies. In the event Rosenbaum’s continued participation in any such benefit plan or insurance policy is barred by the provisions of the plan or policy, Corporation
will arrange to provide Rosenbaum with benefits substantially similar to those which Rosenbaum was entitled to receive under the plan or policy; provided, however, that any payments or reimbursements from Corporation that are not exempt from
taxation under Sections 105 or 106 of the Internal Revenue Code must be made by Corporation no later than March 15, 2012. 
 2.3
Expenses. Subject to review and approval by the chairman of Corporation’s audit committee, Corporation will reimburse Rosenbaum for reasonable expenses, including travel expenses for himself (and his spouse whenever she accompanies him
on a trip which involves Corporation’s business), actually incurred by Rosenbaum in connection with the business of Corporation. Rosenbaum will submit to Corporation such substantiation for such expenses as may be reasonably required by
Corporation. 
 3. CONFIDENTIAL INFORMATION 
 3.1 Definition. “Confidential Information” is all nonpublic information relating to Corporation or its business that is disclosed to Rosenbaum, that Rosenbaum produces, or that Rosenbaum otherwise obtains during employment.
Confidential Information also includes information received from third parties that Corporation has agreed to treat as confidential. Examples of Confidential Information include, without limitation, marketing plans, customer lists or other customer
information, product design and manufacturing information, and financial information. Confidential Information does not include any information that (i) is within the public domain other than as a result of disclosure by Rosenbaum in violation
of this Agreement, (ii) was, on or before the date of disclosure to Rosenbaum, already known by Rosenbaum, or (iii) Rosenbaum is required to disclose in any governmental, administrative, judicial, or quasi-judicial proceeding, but only to
the extent that Rosenbaum is so required to disclose and provided that Rosenbaum takes reasonable steps to request confidential treatment of such information in such proceeding. 
 3.2 Access to Information. Rosenbaum acknowledges that in the course of his employment he has had and will have access to Confidential
Information, that such information is a valuable asset of Corporation, and that its disclosure or unauthorized use will cause Corporation substantial harm. 
 3.3 Ownership. Rosenbaum acknowledges that all Confidential Information will continue to be the exclusive property of Corporation (or the third party that disclosed it to Corporation), whether or not prepared
in whole or in part by Rosenbaum and whether or not disclosed to Rosenbaum or entrusted to his custody in connection with his employment by Corporation. 
 3.4 Nondisclosure and Nonuse. Unless authorized or instructed in advance in writing by Corporation, or required by law (as determined by licensed legal counsel), Rosenbaum will not, except as required in the
course of Corporation’s business, during or after his employment, disclose to others or use any Confidential Information, unless and until, and then only to the extent that, such items become available to the public through no fault of
Rosenbaum. 
 3.5 Return of Confidential Information. Upon request by Corporation during or after his employment, and without request
upon termination of employment pursuant to this Agreement, Rosenbaum will deliver immediately to Corporation all written, stored, saved, or otherwise tangible materials containing Confidential Information without retaining any excerpts or copies.

 3.6 Duration. The obligations set forth in this Section 3 will continue beyond the term of employment of Rosenbaum by
Corporation and for so long as Rosenbaum possesses Confidential Information. 
  

					
	EMPLOYMENT AGREEMENT	  	-2-	  	

 4. NONCOMPETITION 
 4.1 Covenant. For a period ending on the last day of the applicable Noncompete Period described in Section 5.7, Rosenbaum will not, within any geographical area where Corporation engages in business:

 (a) Directly or indirectly, alone or with any individual, partnership, corporation, or other entity, become associated
with, render services to, invest in, represent, advise, or otherwise participate in any business, activity, or enterprise which is carrying on any business competitive with the business conducted by Corporation as of the date Rosenbaum’s
employment with Corporation is terminated; provided, however, that nothing contained in this Section 4.1 will prevent Rosenbaum from owning less than 5 percent of any class of equity or debt securities listed on a national securities
exchange or market, provided such involvement is solely as a passive investor; 
 (b) Solicit any business in competition with
the business of Corporation from any individual, firm, partnership, corporation, or other entity that is a customer of Corporation during the 12 months immediately preceding the date Rosenbaum’s employment with Corporation is terminated;

 (c) Employ or otherwise engage, or offer to employ for Rosenbaum or any other person, entity, or corporation, the services
or employment of any person who has been an employee, sales representative, or agent of Corporation during the 12 months preceding the date Rosenbaum’s employment with Corporation is terminated. 
 For purposes of this Section 4, “Corporation” means Corporation and its subsidiaries (whether now existing or subsequently created) and their successors
and assigns. 
 4.2 Severability; Reform of Covenant. If, in any judicial proceeding, a court refuses to enforce this covenant not to
compete because it covers too extensive a geographic area or is too long in its duration, the parties intend that it be reformed and enforced to the maximum extent permitted under applicable law. 
 5. TERMINATION 
 Rosenbaum’s employment under
this Agreement will terminate prior to the end of the Term as follows: 
 5.1 Death. Rosenbaum’s employment will terminate
automatically upon the date of Rosenbaum’s death. 
 5.2 Disability. Company may, at its option, terminate Rosenbaum’s
employment under this Agreement upon written notice to Rosenbaum if Rosenbaum, because of physical or mental incapacity or disability, fails to perform the essential functions of his position, with reasonable accommodation, required of him under
this Agreement for a continuous period of 120 days or any 180 days within any 12-month period. 
 5.3 Termination by Corporation
for Cause. Corporation may terminate Rosenbaum’s employment under this Agreement for Cause at any time. For purposes of this Agreement, “Cause” means: (a) a material breach of this Agreement by Rosenbaum;
(b) Rosenbaum’s refusal, failure, or inability to comply with the general policies or standards of Corporation or to perform any job duties of Rosenbaum; (c) any act of fraud by Rosenbaum, (d) any act of dishonesty by Rosenbaum
involving Corporation or its business; (e) Rosenbaum’s conviction of or a plea of nolo contendere to a felony; or (f) the commission of any act in direct or indirect competition with or materially detrimental to the best interests of
Corporation that is in breach of Rosenbaum’s fiduciary duties to Corporation; provided that Cause will not include any actions or circumstances constituting Cause under (a) or (b) above if Rosenbaum cures such actions or circumstances
within 30 days of receipt of written notice from Corporation setting forth the actions or circumstances constituting Cause. 
 5.4
Termination by Rosenbaum for Good Reason. Rosenbaum may terminate his employment with Corporation under this Agreement for “Good Reason” if Corporation has not cured the actions or circumstances 

  

					
	EMPLOYMENT AGREEMENT	  	-3-	  	

 
which are the basis for such termination within 30 days following receipt by the Board of written notice from Rosenbaum setting forth the actions or
circumstances constituting Good Reason, which notice must be delivered to the Board within 90 days of the initial existence of such actions or circumstances. For purposes of this Agreement, except as expressly provided to the contrary elsewhere
in this Agreement, “Good Reason” means: 
 (a) Failure of Corporation to comply with the material terms of this
Agreement; or 
 (b) The occurrence (without Rosenbaum’s express written consent) of any of the following acts by
Corporation or failures by Corporation to act: 
 (i) A substantial adverse alteration in the nature or status of
Rosenbaum’s title, position, duties, or reporting responsibilities as an executive of Corporation; 
 (ii) A material
reduction in Rosenbaum’s base salary specified in Section 2.1 above; or 
 (iii) The failure by Corporation to
continue to provide Rosenbaum with benefits and participation in Benefit Plans as provided in Section 2.2. 
 5.5 Termination by
Corporation Without Cause. Corporation may terminate Rosenbaum’s employment with Corporation without Cause for any reason or for no reason at any time by written notice to Rosenbaum. 
 5.6 Termination by Rosenbaum Without Good Reason. Rosenbaum may terminate Rosenbaum’s employment with Corporation for any reason other than
Good Reason or for no reason at any time by written notice to the Secretary of the Corporation. 
 5.7 Applicable Noncompete Periods upon
Termination. The duration of Rosenbaum’s obligations under Section 4 (the “Noncompete Period”) will be as follows: 
 5.7.1 In the event Rosenbaum terminates his employment with Corporation for Good Reason under Section 5.4 or Corporation terminates Rosenbaum’s employment with Corporation without Cause under
Section 5.5, the Noncompete Period will continue so long as Rosenbaum is entitled to receive Monthly Severance Payments under Section 6.3.1 (without giving effect to any prepayment pursuant to the Outside Payment Date provision of such
Section or pursuant to Section 6.5). Rosenbaum’s obligations under this Agreement will terminate immediately if Corporation fails to make a Monthly Severance Payment within 15 days after it is due. 
 5.7.2 Subject to extension by Corporation as provided below, in the event Rosenbaum terminates his employment with Corporation other than
for Good Reason under Section 5.6, the Noncompete Period will be one year from the date of termination. Corporation may in its sole discretion extend the Noncompete Period for a period not to extend beyond 24 months from the date the
Noncompete Period would otherwise expire by agreeing to make Monthly Severance Payments to Rosenbaum during the extended Noncompete Period. To extend the Noncompete Period, Corporation must give Rosenbaum written notice (an “Extension
Notice”) no later than 60 days following the date of termination, stating the elected duration of the extended Noncompete Period. The Extension Notice will constitute a binding commitment by Corporation to make Monthly Severance Payments for
the full duration of the extended Noncompete Period and no further extension of the Noncompete Period will be permitted. Rosenbaum’s obligations under this Agreement will terminate immediately if Corporation fails to make a Monthly Severance
Payment within 15 days after it is due. 
 5.7.3 In the event Corporation terminates Rosenbaum’s employment with
Corporation due to the expiration of the Term or for Cause, there will be no Noncompete Period. 
  

					
	EMPLOYMENT AGREEMENT	  	-4-	  	

 6. COMPENSATION UPON TERMINATION 
 6.1 Death. Upon the death of Rosenbaum during the Term, this Agreement will automatically terminate and all rights of Rosenbaum and his heirs, executors and administrators to compensation and other benefits
under this Agreement will cease, except that Rosenbaum’s heirs, executors and administrators, as the case may be, will be entitled to: 
 (a) Accrued base salary through Rosenbaum’s date of death; 
 (b) Other benefits under
Benefit Plans to which Rosenbaum was entitled on Rosenbaum’s date of death in accordance with the terms of such Benefit Plans; and 
 (c) A lump sum payment in the amount of $500,000 less any amounts payable under any life insurance policies purchased by Corporation for the benefit of Rosenbaum’s dependents. 
 6.2 Disability. Upon termination of Rosenbaum’s employment by Corporation pursuant to Section 5.2, all obligations of Corporation under
this Agreement will cease, except that Rosenbaum will be entitled to: 
 (a) Accrued base salary through the date of
Rosenbaum’s termination of employment; and 
 (b) Other benefits under Benefit Plans to which Rosenbaum was entitled upon
such termination of employment in accordance with the terms of such Benefit Plans. 
 6.3 Severance Upon Certain Terminations.

 6.3.1 Termination Without Cause or by Rosenbaum for Good Reason. In the event that prior to the expiration of the
Term, Rosenbaum terminates his employment with Corporation for Good Reason under Section 5.4 or Corporation terminates Rosenbaum’s employment with Corporation without Cause under Section 5.5, Rosenbaum will be entitled to receive
severance equal to the number of full or partial months remaining in the Term multiplied by Rosenbaum’s monthly base salary in effect as of the date of termination, payable in equal monthly installments (each installment, a “Monthly
Severance Payment”); provided that if such termination occurs on or before September 30, 2010, the amount of such Monthly Severance Payments will decrease to $27,083 on October 1, 2010. Monthly Severance Payments will be payable in a
manner consistent with Corporation’s payroll practices for management employees; provided, however, that if the period over which Monthly Severance Payments would otherwise be payable would extend beyond the Outside Payment Date, the unpaid
portion of the aggregate amount of Monthly Severance Payments (plus the unpaid portion of any amounts being paid to or reimbursed to Rosenbaum for medical and dental benefits pursuant to the following two sentences) as of the Outside Payment Date
will be paid to Rosenbaum in a lump sum not later than the Outside Payment Date. Corporation will also continue to provide to Rosenbaum all medical, dental, group life, long-term care and long-term disability insurance benefits to which Rosenbaum
was entitled as of the date of termination through September 30, 2013; provided that such continued participation or coverage is possible under the general terms and provisions of such benefit plans or insurance policies. In the event
Rosenbaum’s continued participation in any such benefit plan or coverage by any such insurance policy is barred by the provisions of the plan or policy, Corporation will arrange to provide Rosenbaum with benefits substantially similar to those
which Rosenbaum was entitled to receive under the plan or policy. Corporation’s obligation to make Monthly Severance Payments and provide the insurance benefits described above to Rosenbaum will terminate if Rosenbaum either individually or as
a director, officer, partner, employee, agent, representative, or consultant with any business, directly or indirectly (a) solicits, diverts, or accepts orders for products or services that are substantially competitive with the products or
services sold by Corporation from any customer of Corporation; (b) engages or prepares to engage in any business that competes with Corporation; or (c) induces or attempts to induce any person who is an employee of Corporation to leave the
employ of Corporation. For purposes of this Agreement, “Outside Payment Date” means the 15th day 

  

					
	EMPLOYMENT AGREEMENT	  	-5-	  	

 
of the third calendar month of the calendar year immediately following the date of termination of Rosenbaum. 
 6.3.2 Termination For Cause or by Rosenbaum Without Good Reason. In the event Corporation terminates Rosenbaum’s employment
with Corporation for Cause under Section 5.3, or Rosenbaum terminates his employment with Corporation for other than Good Reason under Section 5.6, Corporation’s obligations under this Agreement will cease and Rosenbaum will be
entitled to that portion of his base salary and employment benefits for which he is qualified as of the date of termination and Rosenbaum will not be entitled to any other compensation or consideration under this Agreement. 
 6.4 Automobile. Upon Rosenbaum’s termination of employment for any reason, Rosenbaum will surrender possession to Corporation of any
automobile then leased by Corporation for his use and Rosenbaum will have no liability for any payments due or which may become due under such lease. 
 6.5 Compliance with IRS Section 409A. To the extent required by Section 409A of the Internal Revenue Code, and the regulations promulgated thereunder, payment of severance benefits to Rosenbaum under
any provision of Section 6 of this Agreement will not be paid or commenced until the expiration of six months following the date of termination of Rosenbaum’s employment with Corporation. If monthly payments are deferred pursuant to this
Section, all such deferred amounts will be paid in a lump sum on the expiration of the six-month period. 
 6.6 Excess Parachute
Payments. 
 6.6.1 Reduction. In the event that any portion of the payments and benefits payable to Rosenbaum under
Section 6.3.1 would constitute an “excess parachute payment” within the meaning of IRC § 280G(b) that is subject to the excise tax imposed on so-called excess parachute payments pursuant to IRC §4999 (an
“Excise Tax”), the severance otherwise payable under Section 6.3.1 will be reduced to the extent necessary to avoid such Excise Tax if, and only if, such reduction would result in a larger after-tax benefit to Rosenbaum, taking into
account all applicable federal, state, and local income and excise taxes, until either (i) no portion of the severance payments is subject to such Excise Tax or (ii) the payments are reduced to zero. 
 6.6.2 Application. For purposes of this Section 6.6: 
 (a) No portion of any severance or other compensation, the receipt or enjoyment of which Rosenbaum has effectively waived in writing prior
to the date of payment of any post-termination compensation, will be taken into account; 
 (b) No portion of any severance or
other compensation will be taken into account which, in the opinion of tax counsel selected by Corporation and reasonably acceptable to Rosenbaum (“Tax Counsel”), does not constitute a “parachute payment” within the meaning of
IRC § 280G; 
 (c) If Rosenbaum and Corporation disagree whether any payment will result in an Excise Tax or
whether a reduction in any payments will result in a larger after-tax benefit to Rosenbaum, the matter will be conclusively resolved by an opinion of Tax Counsel; 
 (d) Rosenbaum agrees to provide Tax Counsel with all financial information necessary to determine the after-tax consequences of payments
for purposes of determining whether, or to what extent, such payments are to be reduced pursuant to Section 6.6.1; and 
 (e) The value of any noncash benefit or any deferred payment or benefit, and whether or not all or a portion of any payment or benefit is a “parachute payment” for purposes of this Section 6.6, will be determined by
Corporation’s independent accountants in accordance with the principles of IRC § 280(G)(d)(3) and (4). 
  

					
	EMPLOYMENT AGREEMENT	  	-6-	  	

 6.6.3 Effect on Other Agreements. In the event that any other agreement, plan, or
arrangement providing for payments to Rosenbaum (an “Other Agreement”) has a provision that requires a reduction in the payments governed by such Other Agreement to avoid or eliminate an “excess parachute payment” for purposes of
IRC § 280G, the reduction in payments pursuant to Section 6.6.1 will be given effect before any reduction in the payments pursuant to the Other Agreement. To the extent possible, Corporation and Rosenbaum agree that reductions in
benefits under any plan, program, or arrangement of Corporation will be reduced (only to the extent described in Section 6.6.1) in the following order of priority: 
 (a) Post-termination payments under this Agreement; 
 (b) Benefit Plan benefit continuation pursuant to Section 6.3.1; and 
 (c) The acceleration in the exercisability of any stock option or other stock related award granted by Corporation. 
 7. REMEDIES 
 The respective rights and duties of
Corporation and Rosenbaum under this Agreement are in addition to, and not in lieu of, those rights and duties afforded to and imposed upon them by law or in equity. Rosenbaum acknowledges that any breach or threatened breach of Section 3 or 4
of this Agreement will cause irreparable harm to Corporation and that any remedy at law would be inadequate to protect the legitimate interests of Corporation. Rosenbaum agrees that Corporation will be entitled to specific performance, or to any
other form of injunctive relief to enforce its rights, under Section 3 or 4 of this Agreement without the necessity of showing actual damage or irreparable harm or the posting of any bond or other security. Such remedy will be in addition to
any other remedy available to Corporation by law or in equity. 
 8. SEVERABILITY OF PROVISIONS 
 The provisions of this Agreement are severable, and if any provision of this Agreement is held invalid, unenforceable, or unreasonable, it will be
enforced to the maximum extent permissible, and the remaining provisions of the Agreement will continue in full force and effect. 
 9. NONWAIVER 

 Failure of Corporation at any time to require performance of any provision of this Agreement will not limit the right of Corporation to
enforce the provision. No provision of this Agreement or breach of this Agreement may be waived by either party except in writing signed by that party. A waiver of any breach of a provision of this Agreement will be construed narrowly and will not
be deemed to be a waiver of any succeeding breach of that provision or a waiver of that provision itself or of any other provision. 
 10. NOTICES 

 All notices required or permitted under this Agreement must be in writing and will be deemed to have been given if delivered by hand, or
mailed by first-class, certified mail, return receipt requested, postage prepaid, to the respective parties as follows (or to such other address as any party may indicate by a notice delivered to the other parties hereto): (i) if to Rosenbaum,
to his residence as listed in Corporation’s records, and (ii) if to Corporation, to the address of the principal office of Corporation, at: 
 One Airport Center 
 7700 N.E. Ambassador Place 
 Portland, Oregon 97220 
 11. ATTORNEY FEES 

The prevailing party in any suit, action, arbitration, or appeal filed or held concerning this Agreement will be entitled to reasonable attorneys’
fees. For purposes of this Agreement, “prevailing party” means the party that 

  

					
	EMPLOYMENT AGREEMENT	  	-7-	  	

 
prevails (whether affirmatively or by means of a successful defense) with respect to claims having the greatest value or importance as reasonably determined
by the court. 
 12. GOVERNING LAW 
 This
Agreement will be construed in accordance with the laws of the state of Oregon, without regard to any conflicts of laws rules. Any suit or action arising out of or in connection with this Agreement, or any breach of this Agreement, must be brought
and maintained in the Circuit Courts of the State of Oregon. The parties hereby irrevocably submit to the jurisdiction of such court for the purpose of such suit or action and hereby expressly and irrevocably waive, to the fullest extent permitted
by law, any claim that any such suit or action has been brought in an inconvenient forum. 
 13. GENERAL TERMS AND CONDITIONS 
 This Agreement, as amended and restated effective June 15, 2009, constitutes the entire understanding of the parties relating to the employment of
Rosenbaum by Corporation, and supersedes and replaces all prior written and oral agreements by and between the parties relating thereto; provided that Corporation and Rosenbaum specifically acknowledge and agree that any award agreements entered
into between Corporation and Rosenbaum pursuant to Corporation’s stock-based compensation plans, including without limitation its 2005 Stock Incentive Plan and its Stock Appreciation Rights Plan, are not affected by and exist separate and apart
from this Agreement. Rosenbaum acknowledges that he has read and understood all of the provisions of this Agreement, that the restrictions contained in Sections 4 and 5.7 of this Agreement are reasonable and necessary for the protection of
Corporation’s business and that Rosenbaum entered into this Agreement in connection with a bona fide advancement of Rosenbaum with Corporation in that Rosenbaum was granted a long-term employment contract. This Agreement will inure to the
benefit of any successors or assigns of Corporation. All captions used in this Agreement are intended solely for convenience of reference and will in no way limit any of the provisions of this Agreement. 
 The parties have executed this Amended and Restated Employment Agreement as of the date stated above. 
  

							
		 		 	RENTRAK CORPORATION
				
	 /s/    Paul A. Rosenbaum
	 		 	By	 	 /s/    Judith G. Allen

	Paul A. Rosenbaum	 		 	Name:	 	Judith G. Allen
		 		 	Title:	 	Chair, Compensation Committee

  

					
	EMPLOYMENT AGREEMENT	  	-8-Consulting Agreement

 Exhibit 10.1 
 CONSULTING AGREEMENT 
 This Consulting Agreement (this “Agreement”) is entered into
as of June 1, 2009 (the “Effective Date”), by and between EnteroMedics Inc. (the “Company”), a Delaware corporation, whose principal place of business is 2800 Patton Road, St. Paul, MN 55113, and Nicholas L. Teti, Jr. (the
“Consultant”), whose address is                     . 
 WHEREAS, the Consultant currently serves as a member of the Company’s Board of Directors; 
 WHEREAS,
the Company desires that the Consultant provide additional services to the Company as an independent contractor and the Consultant desires to provide such additional services as an independent contractor. 
 NOW, THEREFORE, in consideration of the mutual representations, promises and agreements contained herein, the adequacy and sufficiency of which are
hereby acknowledged, the Company and the Consultant hereby agree as follows: 
 1. Term of Agreement. The Company hereby engages the
Consultant as a consultant, subject to the terms and conditions hereof, for the period commencing as of the Effective Date and ending on June 1, 2010 (the “Term”), except as the Term may be extended by mutual written agreement of the
parties hereto or earlier terminated as hereafter provided. The period during which the Consultant is performing services under this Agreement shall be referred to herein as the “Consulting Period.” 
 2. Consulting Services. During the Consulting Period, the Consultant shall perform consulting services for the Company. Such consulting services
are anticipated to include, but not limited to, working with Company management at a strategic level with respect to the Company’s commercialization planning, business and corporate development activities and investor relations. During the
Term, the Consultant will devote 160 hours per month to accomplishing his duties and responsibilities under this Agreement. Consultant shall make himself available in person for meetings and consultation with Company employees at the Company’s
headquarters in St. Paul, Minnesota upon reasonable request. Consultant’s principal contact at EnteroMedics shall be Mark B. Knudson, Ph.D., and Consultant shall accept instructions/directions from and report to this contact person or any other
designee specified by Dr. Knudson. 
 3. Independent Contractor. 
 (a) The Consultant shall perform the consulting services described in Section 2 as an independent contractor without the power to bind or represent
the Company for any purpose whatsoever. Nothing herein contained shall be construed to constitute the parties hereto as partners or as joint venturers, or either as agent of the other, or as employer and employee. The Consultant shall not present
himself as an employee of the Company or any of its affiliates. 
 (b) The Consultant shall not be entitled to participate in any employee
benefit plans maintained by on behalf of the Company or any of its affiliates during the Consulting Period. The Consultant hereby acknowledges his separate responsibility for all federal and state withholding taxes, Federal Insurance Contribution
Act taxes, workers’ compensation and unemployment compensation taxes and business license fees, if applicable. 

 4. Compensation. 
 (a) Consulting Fee. In remuneration for the consulting services to be performed under this Agreement by the Consultant during the Consulting Period, the Consultant shall receive an annual consulting fee equal
to two hundred seventy-five thousand dollars ($275,000) (the “Consulting Fee”), payable no less frequently than monthly in arrears. The Consulting Fee shall be in addition to, and not in lieu of, those fees or other remuneration to which
the Consultant may be entitled pursuant to Company policies in his position as member of the Board of Directors. 
 (b) Equity Award.
As additional compensation for the consulting services to be performed by the Consultant under this Agreement, the Company shall grant the Consultant a non-qualified option to purchase one hundred fifty thousand (150,000) shares of the
Company’s common stock at the closing market price of the Company’s common stock on the date such award is approved by the Company’s Board of Directors. This option shall have a 10-year term and shall vest one-thirtysixth per month
for three years and shall be vested in full on the third anniversary of the grant date. 
 5. Expenses. The Company will reimburse
Consultant for actual incidental expenses (with no increase for handling or other mark-up) incurred in performing this Agreement, but such expenses shall not exceed one hundred dollars ($100) per month without the Company’s prior written
consent. Travel expenses must be approved in advance by the Company. Consultant shall provide the Company with appropriate documentation for tax purposes for all expenses paid by the Company. Consultant shall submit monthly invoices for time and
expenses. 
 6. Termination. During the Term, this Agreement and the Consulting Period may be terminated at any time by the Company or
the Consultant, with or without cause, upon thirty (30) days’ prior written notice to the other party. The Agreement may be terminated by the Company immediately for any willful breach by Consultant of this Agreement or any willful
misconduct or malfeasance by Consultant that may be detrimental or harmful to the Company. In the event of the termination of this Agreement pursuant to this Section 6, the Company’s obligations under Section 4(a) shall cease on the
effective date of such termination. In the event of the Consultant’s death or permanent disability, the Agreement and Consulting Period shall terminate. The provisions of this Section 6, as well as Sections 7, 8, 9 and 15 shall survive the
expiration or termination of this Agreement and shall remain in full force and effect in accordance with the terms thereof. 
 7. Exclusivity. Due to the confidential nature of the information which will be disclosed to Consultant in connection with his performance of the consulting services under this Agreement, Consultant shall not do any other consulting
work for any other third party in the area of the Company’s products, services or Technology or for any competitor or potential competitor of the Company during the Term and for a period of six months thereafter without prior approval by the
Company. The Company’s “Technology” shall include the Company’s proprietary VBLOCTM, vagal blocking therapy, and MaestroTM System or
any similar device or 

 
related processes, products or services related to obesity management or treatment of gastrointestinal disorders, including, without limitation, the use of
neuroblocking or neurostimulation to treat obesity, its associated co-morbidities, metabolic syndrome and gastrointestinal disorders. 
 8.
Confidential Information; Non-Solicitation. The parties hereto recognize that a major need of the Company is to preserve its specialized knowledge, trade secrets, and confidential information. The strength and good will of the Company is
derived from the specialized knowledge, trade secrets, and confidential information generated from experience with the activities undertaken by the Company. The disclosure of this information and knowledge to competitors would be beneficial to them
and detrimental to the Company. The Consultant acknowledges that the proprietary information, observations and data obtained by him during the Consulting Period concerning the business or affairs of the Company are the property of the Company. By
reason of being a member of the Company’s Board of Directors and through the services provided under this Agreement, the Consultant has or will have access to, and has obtained or will obtain, specialized knowledge, trade secrets and
confidential information about the Company’s operations. Therefore, the Consultant hereby agrees as follows, recognizing that the Company is relying on these agreements in entering into this Agreement: 
 (a) The Consultant will not use, disclose to others, or publish or otherwise make available to any other party any inventions or any Confidential
Information about the affairs of the Company, including but not limited to confidential information concerning the results of the Company’s clinical trials and financial condition. “Confidential Information” shall include any
information considered by the Company to be confidential and/or proprietary that is disclosed by the Company to Consultant, all confidential information of third parties that is to be held as confidential by the Company, commercial or trade secrets
about Company’s proprietary Technology, products, devices and methods, as well as information about the Company’s engineering designs, plans and standards, commercial plans, sales and marketing plans, techniques and reports, analytical
techniques, technical information, employee information, or financial and business records, any of which contains proprietary information created or acquired by the Company and which information is held in confidence by Company. Confidential
Information does not include information which: (i) becomes generally available to the public, unless said Confidential Information was disclosed in violation of a confidentiality agreement; or (ii) becomes available to the Consultant on a
non-confidential basis from a source other than the Company or its agents, provided that such source is not bound by a confidentiality agreement with the Company or has not breached a duty of confidentiality to the Company in disclosing such
information. 
 (b) During the Term and for twelve (12) months thereafter, the Consultant will not directly or indirectly through
another entity (i) induce any employee of the Company to leave the Company’s employ (unless the Board of Directors shall have authorized such employment and the Company shall have consented thereto in writing) or in any way interfere with
the relationship between the Company and any employee thereof or (ii) tortuously interfere with the Company’s business relationship with any supplier, customer, vendor, clinical trial sponsor or other business relation of the Company.

 9. Intellectual Property; Works of Authorship. 
 (a) Consultant agrees to disclose promptly to the Company all inventions, improvements, know-how, formulas, trade secrets, secret processes, technical
information, or any other intellectual property (other than works of authorship) made or conceived, either alone or jointly with others, during the term of this Agreement and for six (6) months thereafter as a result of the services provided
pursuant to this Agreement or of the Confidential Information obtained by Consultant during the term of this Agreement or any extension thereof. Consultant agrees that the Company shall be the exclusive owner of the entire right, title, and interest
in and to any and all such intellectual property, including any patent applications and any patents that may issue therefrom anywhere in the world. Consultant agrees to assign all right, title, and interest in and to such intellectual property to
the Company without further payment from the Company. Consultant also agrees that, upon the Company’s request and at the Company’s expense, Consultant will provide reasonable assistance to the Company in prosecuting, maintaining, and
protecting patents covering any such intellectual property. 
 (b) Any original work of authorship including any written, pictorial, graphic
or audiovisual work, sound recording, courseware design or architecture in any form including, but not limited to, computer generated files and code, created by the Consultant in the course of providing services to the Company under this Agreement
shall be deemed as “works made for hire” and be the sole property of the Company and the Company shall own all the rights including the rights to copyright in the work. To the extent that any of the foregoing does not qualify as a
“work made for hire,” Consultant hereby irrevocably transfers, assigns and conveys the exclusive copyright ownership thereof to the Company, free and clear of any liens, claims or other encumbrances, to the fullest extent permitted by law.
Consultant agrees to execute all documents and perform all acts that the Company may reasonably request in order to assist the Company in perfecting its rights in and to the works developed under this Agreement anywhere in the world. The Company
will reimburse Consultant for any expenses reasonably incurred by Consultant in so doing. 
 (c) The obligations to assign inventions and
copyrights to the Company shall not apply to any invention or copyrights for which no equipment, supplies, facility or trade secret information of the Company was used and which was developed entirely on the Consultant’s own time, and
(1) which does not relate (a) directly to the business of the Company or (b) to the Company’s actual or demonstrably anticipated research or development, or (2) which does not result from any work performed by the Consultant
for the Company. 
 10. Entire Agreement. This Agreement sets forth the entire agreement and understanding of the parties hereto with
respect to the matters covered hereby and supersedes any prior agreement or understanding whether oral or written between the parties with respect to the matters covered hereby. Nothing in this Agreement shall be construed to grant Consultant any
right of service on the Company’s Board of Directors or committee thereof. 
 11. Notices. All notices required or permitted by
this Agreement shall be in writing and may be delivered in person, sent by certified or registered mail, return receipt required, postage paid to the addresses stated above or to such other address as either party may designate or by facsimile to
such facsimile number as either party may designate. All mailing notices shall be deemed effective upon depositing in the mail. 

 12. Waiver. The waiver of either party of a breach of any provision of this Agreement shall not
operate as or be construed as a continuing waiver or as a consent to or waiver of such subsequent breach. 
 13. Modification. This
Agreement may only be modified in writing signed by both parties. 
 14. Nonassignable. Since the consulting services to be provided
under this Agreement are personal, all duties to be performed by Consultant may not be assigned to any other individual or third party without the written consent of the Company. 
 15. Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Minnesota, without
regard to its principles of conflicts of laws. ANY RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY CLAIM, ACTION, SUIT OR PROCEEDING ARISING OUT OF THIS AGREEMENT OR ANY OF THE MATTERS CONTEMPLATED HEREBY IS WAIVED BY THE COMPANY AND CONSULTANT. THE
COMPANY AND CONSULTANT HEREBY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE FEDERAL AND STATE COURTS LOCATED IN HENNEPIN COUNTY, MINNESOTA, IN CONNECTION WITH ANY DISPUTE RELATED TO THIS AGREEMENT OR ANY OF THE MATTERS CONTEMPLATED HEREBY. 

16. Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be
excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms. 
 17. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original and all of which
together shall constitute one and the same instrument. 
 (remainder of page intentionally left blank) 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above
written. 
  

			
	ENTEROMEDICS INC.
		
	By:	 	 /s/ Mark B. Knudson, Ph.D.

	Name:	 	Mark B. Knudson, Ph.D.
	Title:	 	President and Chief Executive Officer
	
	CONSULTANT
	
	 /s/ Nicholas L. Teti, Jr.

	Nicholas L. Teti, Jr.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}]]